You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國產手術機器人攻克“腹部手術珠峯”!首程生態助力醫療科技破局
格隆匯 07-16 08:39

近日,北京大學首鋼醫院肝膽胰外科中心成功實施全球首例由國產SHURUI蛇形臂單孔手術機器人主導的胰十二指腸切除術。該手術因操作複雜、風險極高,被譽為“腹部手術皇冠上的明珠”,此前長期被國際設備壟斷。此次突破標誌着國產高端手術機器人在複雜腹部手術領域實現從“跟隨”到“引領”的跨越。此次手術的SHURUI機器人,是首程控股在2025年6月機器人產業大會上籤約的50餘家生態企業之一。首程創新採用“租賃模式”推動設備快速入院,並通過整合產業鏈資源、對接臨牀場景,加速技術轉化。公司強調“科技落地驅動真實價值”,已構建覆蓋醫療、園區、停車等多場景的機器人應用生態,並打通B端與C端協同渠道。除醫療領域外,首程控股重點投資的宇樹科技近期亮相國務院新聞辦記者會。首程通過旗下北京機器人產業發展投資基金對宇樹連續追加投資,強化“鏈主企業+場景協同”戰略,推動技術從實驗室走向規模化應用。總的來説,本次手術驗證了國產機器人在核心場景替代進口設備的潛力。專家指出,國產單孔技術打破達芬奇SP系統壟斷,其靈活性與性價比更適配基層推廣。首程控股表示,未來將深化“投資入局、運營共建、借江成海”三步走戰略,通過資本與場景雙輪驅動,助力中國機器人產業構建自主生態,參與全球競爭。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account